UniProt ID | LRFN3_HUMAN | |
---|---|---|
UniProt AC | Q9BTN0 | |
Protein Name | Leucine-rich repeat and fibronectin type-III domain-containing protein 3 | |
Gene Name | LRFN3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 628 | |
Subcellular Localization |
Cell membrane Single-pass type I membrane protein. Cell projection, axon. Cell projection, dendrite. Cell junction, synapse. Cell junction, synapse, presynaptic cell membrane. Cell junction, synapse, postsynaptic cell membrane. |
|
Protein Description | Cell adhesion molecule that mediates homophilic cell-cell adhesion in a Ca(2+)-independent manner. Promotes neurite outgrowth in hippocampal neurons (By similarity).. | |
Protein Sequence | MAILPLLLCLLPLAPASSPPQSATPSPCPRRCRCQTQSLPLSVLCPGAGLLFVPPSLDRRAAELRLADNFIASVRRRDLANMTGLLHLSLSRNTIRHVAAGAFADLRALRALHLDGNRLTSLGEGQLRGLVNLRHLILSNNQLAALAAGALDDCAETLEDLDLSYNNLEQLPWEALGRLGNVNTLGLDHNLLASVPAGAFSRLHKLARLDMTSNRLTTIPPDPLFSRLPLLARPRGSPASALVLAFGGNPLHCNCELVWLRRLAREDDLEACASPPALGGRYFWAVGEEEFVCEPPVVTHRSPPLAVPAGRPAALRCRAVGDPEPRVRWVSPQGRLLGNSSRARAFPNGTLELLVTEPGDGGIFTCIAANAAGEATAAVELTVGPPPPPQLANSTSCDPPRDGDPDALTPPSAASASAKVADTGPPTDRGVQVTEHGATAALVQWPDQRPIPGIRMYQIQYNSSADDILVYRMIPAESRSFLLTDLASGRTYDLCVLAVYEDSATGLTATRPVGCARFSTEPALRPCGAPHAPFLGGTMIIALGGVIVASVLVFIFVLLMRYKVHGGQPPGKAKIPAPVSSVCSQTNGALGPTPTPAPPAPEPAALRAHTVVQLDCEPWGPGHEPVGP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
24 | O-linked_Glycosylation | SSPPQSATPSPCPRR CCCCCCCCCCCCCCC | 29.55 | OGP | |
81 | N-linked_Glycosylation | VRRRDLANMTGLLHL HHHHHHHHCHHHEHH | 35.53 | UniProtKB CARBOHYD | |
89 | Phosphorylation | MTGLLHLSLSRNTIR CHHHEHHHCCHHHHH | 17.35 | 24719451 | |
91 | Phosphorylation | GLLHLSLSRNTIRHV HHEHHHCCHHHHHHH | 21.80 | 22210691 | |
218 | Phosphorylation | MTSNRLTTIPPDPLF CCCCCCCCCCCCCHH | 35.76 | - | |
339 | N-linked_Glycosylation | PQGRLLGNSSRARAF CCCCCCCCCHHCEEC | 36.46 | UniProtKB CARBOHYD | |
348 | N-linked_Glycosylation | SRARAFPNGTLELLV HHCEECCCCCEEEEE | 50.02 | UniProtKB CARBOHYD | |
393 | N-linked_Glycosylation | PPPPQLANSTSCDPP CCCCCCCCCCCCCCC | 55.18 | UniProtKB CARBOHYD | |
409 | Phosphorylation | DGDPDALTPPSAASA CCCCCCCCCCCHHHH | 34.57 | 27732954 | |
412 | Phosphorylation | PDALTPPSAASASAK CCCCCCCCHHHHCCE | 37.36 | 27732954 | |
415 | Phosphorylation | LTPPSAASASAKVAD CCCCCHHHHCCEECC | 23.60 | 27732954 | |
417 | Phosphorylation | PPSAASASAKVADTG CCCHHHHCCEECCCC | 26.57 | 27732954 | |
457 | Phosphorylation | PIPGIRMYQIQYNSS CCCCEEEEEEEECCC | 7.82 | - | |
462 | N-linked_Glycosylation | RMYQIQYNSSADDIL EEEEEEECCCCCCEE | 17.08 | UniProtKB CARBOHYD | |
463 | Phosphorylation | MYQIQYNSSADDILV EEEEEECCCCCCEEE | 23.20 | - | |
464 | Phosphorylation | YQIQYNSSADDILVY EEEEECCCCCCEEEE | 31.89 | - | |
503 | Phosphorylation | VLAVYEDSATGLTAT EEEEEECCCCCCEEC | 18.78 | - | |
505 | Phosphorylation | AVYEDSATGLTATRP EEEECCCCCCEECCC | 36.35 | - | |
580 | Phosphorylation | AKIPAPVSSVCSQTN CCCCCCHHHHHCCCC | 18.92 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LRFN3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LRFN3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LRFN3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of LRFN3_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-91, AND MASSSPECTROMETRY. |